Licensed, NICE-approved alternatives for weight management including semaglutide (Wegovy) and tirzepatide (Zepbound) are available through NHS and regulated private UK healthcare pathways
Always consult with a healthcare provider before integrating BPC-157 with other dietary supplements to ensure compatibility and safety, especially since BPC-157 is not FDA-approved and primarily supported by preclinical research
Chen S, Weitemier AZ, Zeng X, He L, Wang X, Tao Y, et al
Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption
It is estimated that 40% of people may be lacking in Vitamin B12
Not all weight loss peptides use weight-based dosing